Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 66.51 PB Ratio: 6.55 GF Score: 92/100

Bio-Techne Corp at Jefferies Healthcare Conference Transcript

Jun 08, 2022 / 01:30PM GMT
Release Date Price: €83.5 (+0.60%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Okay. We'll go ahead and get started. Thanks, everybody, for being here. Good morning. Welcome to the Jefferies 2022 Global Healthcare Conference back in person. It's great to see everybody. I'm Brandon Couillard, I cover the life science tools and diagnostics space. Very happy to have Bio-Techne with us back at the conference this year. And here to share an update with us, CEO, Chuck Kummeth. Chuck?

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Thank you. Is this working? Can you hear me? Good.

All right. Well, we'll get this started. It's been a while since we have given a presentation actually, so it's good to be back.

All right, good. First, our safe harbor. You guys have all seen these before, but we recommend you go online and look at our reconciliations and see all the real data.

Overview of our company. We're about a $15 billion company as of January to now. Like everybody else, we've come down a fair amount, but not as much as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot